MINIMUM FULL SEQUENCES OF 2^N-M RESOLUTION III PLANS.PAJAK TF; ADDELMAN S.1975; J. R. STATIST. SOC., B; G.B.; DA. 1975; VOL. 37; NO 1; PP. 88-95; BIBL. 11 REF.Article

PHASE II STUDY OF CHLOROZOTOCIN IN NON-SMALL CELL CARCINOMA OF THE LUNGCORNELL CJ JR; HOTH D; PAJAK TF et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 734-735; BIBL. 5 REF.Article

HYPERSENSITIVITY REACTIONS TO IV MELPHALAN DURING TREATMENT OF MULTIPLE MYELOMA: CANCER AND LEUKEMIA GROUP B EXPERIENCECORNWELL GG III; PAJAK TF; MCINTYRE OR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 3; PP. 399-403; BIBL. 10 REF.Article

MAINTENANCE MANAGEMENT OF ACUTE NONLYMPHOCYTIC LEUKEMIALEWIS JP; PAJAK TF; LINMAN JW et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 2; PP. 115-124; BIBL. 14 REF.Article

ADRIAMYCIN VERSUS ADRIAMYCIN AND BLEOMYCIN IN ADVANCED EPIDERMOID CARCINOMA OF THE CERVIX.GREENBERG BR; KARDINAL CG; PAJAK TF et al.1977; CANCER TREATM. REP.; U.S.A.; DA. 1977; VOL. 61; NO 7; PP. 1383-1384; BIBL. 5 REF.Article

THYMIC IRRADIATION. AN APPROACH TO CHRONIC LYMPHOCYTIC LEUKEMIA = L'IRRADIATION DU THYMUS. UNE APPROCHE DE LA LEUCEMIE LYMPHOIDE CHRONIQUERICHARS F; SPURR CL; PAJAK TF et al.1974; AMER. J. MED.; U.S.A.; DA. 1974; VOL. 67; NO 6; PP. 862-869; BIBL. 21 REF.Article

SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNG. THE CANCER AND LEUKEMIA GROUP B EXPERIENCECHAHINIAN AP; COMIS RL; MAURER LH et al.1982; BULL. CANCER; ISSN 0007-4551; FRA; DA. 1982; VOL. 69; NO 1; PP. 79-82; ABS. FRE; BIBL. 7 REF.Article

EARLY REHABILITATIVE CARE IN COMMUNITY HOSPITALS: EFFECTS ON QUALITY OF SURVIVORSHIP FOLLOWING A STROKE = LA REEDUCATION PRECOCE DANS LES HOPITAUX CIVILS: EFFETS SUR LA QUALITE DE LA SURVIE APRES UN ACCIDENT VASCULAIRE CEREBRALTRUSCOTT BL; KRETSCHMANN CM; TOOLE JF et al.1975; STROKE; U.S.A.; DA. 1975; VOL. 5; NO 5; PP. 623-629; BIBL. 15REF.Article

TRIAL OF 1-(2-CHLOROETHYL) 3-CYCLOHEXYL-1-NITROSUREA (CCNU: NSC-79037) IN ADVANCED BRONCHOGENIC CARCINOMASTOLINSKY DC; BULL FE; PAJAK TF et al.1975; ONCOLOGY; SWITZ.; DA. 1975; VOL. 31; NO 5-6; PP. 288-292; BIBL. 4 REF.Article

INFLUENCE OF RENAL FAILURE ON MYELOSUPPRESSIVE EFFECTS OF MELPHALAN: CANCER AND LEUKEMIA GROUP B EXPERIENCECORNWELL GG III; PAJAK TF; MCINTYRE OR et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 3; PP. 475-481; BIBL. 5 REF.Article

PROCARBAZINE, VINBLASTINE, AND ACTINOMYCIN D IN STAGE III AND IV MELANOMA WITH OR WITHOUT METHANOL-EXTRACTED RESIDUE OF BACILLUS CALMETTE-GUERINKOSTINAS JE; LEONE LA; CUTTNER J et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 2; PP. 197-200; BIBL. 14 REF.Article

MULTIPLE MYELOMA RESISTANT TO MELPHALAN: TREATMENT WITH DOXORUBICIN, CYCLOPHOSPHAMIDE, CARMUSTINE (BCNU), AND PREDNISONEKYLE RA; PAJAK TF; HENDERSON ES et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 3; PP. 451-456; BIBL. 24 REF.Article

PHASE II TRIAL OF CIS-DICHLORODIAMMINEPLATINUM(II) IN ADVANCED MALIGNANT LYMPHOMA: A STUDY OF THE CANCER AND ACUTE LEUKEMIA GROUP BCAVALLI F; JUNGLI WF; NISSEN NJ et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 48; NO 9; PP. 1927-1930; BIBL. 10 REF.Article

A RANDOMIZED COMBINED MODALITY TRIAL IN SMALL CELL CARCINOMA OF THE LUNG: COMPARISON OF COMBINATION CHEMOTHERAPY-RADIATION THERAPY VERSUS CYCLOPHOSPHAMIDE-RADIATION THERAPY EFFECTS OF MAINTENANCE CHEMOTHERAPY AND PROPHYLACTIC WHOLE BRAIN IRRADIATIONMAURER LH; TULLOH M; WEISS RB et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 1; PP. 30-39; BIBL. 27 REF.Article

MULTIPLE MYELOMA RESISTANT TO MELPHALAN: TREATMENT WITH CYCLOPHOSPHAMIDE, PREDNISONE AND BCNUKYLE RA; GAILANI S; SELIGMAN BR et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 8; PP. 1265-1269; BIBL. 20 REF.Article

LUNG CANCER AS A SECOND PRIMARYREYNOLDS RD; PAJAK TF; GREENBERG BR et al.1978; CANCER; USA; DA. 1978; VOL. 42; NO 6; PP. 2887-2893; BIBL. 15 REF.Article

THE SUPERIORITY OF CCNU IN THE TREATMENT OF ADVANCED HODGKIN'S DISEASE: CANCER AND LEUKEMIA GROUP B STUDYHANSEN HH; SELAWRY OS; PAJAK TF et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 1; PP. 14-18; BIBL. 14 REF.Article

CONSIDERATIONS IN DESIGNING AND ANALYZING SURGICAL ADJUVANT STUDY IN RESECTED STAGE I AND II CARCINOMA OF THE LUNGREYNOLDS RD; PAJAK TF; BATEMAN JR et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 4; PP. 1201-1210; BIBL. 20 REF.Article

EFFECT OF THE METHANOL EXTRACTION RESIDUE OF BACILLUS CALMETTE-GUERIN IN ADVANCE HODGKIN'S DISEASECOOPER MR; PAJAK TF; NISSEN NI et al.1982; CANCER; ISSN 0008-543X; USA; DA. 1982; VOL. 49; NO 11; PP. 2226-2230; BIBL. 32 REF.Article

COMBINATION CHEMOTHERAPY FOR NON-HODGKIN LYMPHOMAS: A TEN YEAR FOLLOW-UP STUDYHAYES DM; PAJAK TF; VISHRAM REGE et al.1979; MED. PEDIATR. ONCOL.; USA; DA. 1979; VOL. 6; NO 1; PP. 23-38; BIBL. 21 REF.Article

MER IMMUNOTHERAPY AND COMBINATION CHEMOTHERAPY FOR ADVANCED, RECURRENT HODGKIN'S DISEASE: CANCER AND LEUKEMIA GROUP B STUDYVINCIGUERRA V; COLEMAN M; PAJAK TF et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 2; PP. 99-105; BIBL. 21 REF.Article

CLINICAL TRIAL OF VP16-213 (NSC 141540) I.V. TWICE WEEKLY IN ADVANCED NEOPLASTIC DISEASE: A STUDY BY THE CANCER AND LEUKEMIA GROUP BNISSEN NI; PAJAK TF; LEONE LA et al.1980; CANCER; USA; DA. 1980; VOL. 45; NO 2; PP. 232-235; BIBL. 6 REF.Article

A NEW EFFECTIVE FOUR-DRUG COMBINATION OF CCNU (1-(2-CHLOROETHYL)-3-CYCLOHEXYL-1-NITROSOUREA) (NSC-79038) VINBLASTINE, PREDNISONE, AND PROCARBAZINE FOR THE TREATMENT OF ADVANCED HODKGIN'S DISEASECOOPER MR; PAJAK TF; NISSEN NI et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 4; PP. 654-662; BIBL. 35 REF.Article

A COMPARATIVE STUDY OF A BCNU CONTAINING 4-DRUG PROGRAM VERSUS MOPP VERSUS 3-DRUG COMBINATIONS IN ADVANCED HODGKIN'S DISEASE: A COOPERATIVE STUDY BY THE CANCER AND LEUKEMIA GROUP BNISSEN NI; PAJAK TF; GLIDEWELL O et al.1979; CANCER; USA; DA. 1979; VOL. 43; NO 1; PP. 31-40; BIBL. 24 REF.Article